Atlas Trials

Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism

Clinical trial NCT05686993 · COMPLETED

Trial details

NCT number
NCT05686993
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary AldosteronismEndocrine Hypertension
Start date
2023-04-24
Primary completion
2023-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.